Kazia Therapeutics Limited
KZIA
$13.16
-$0.67-4.85%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.72M | -14.01M | -13.41M | -16.04M | -18.73M |
| Total Depreciation and Amortization | -400.00 | 304.10K | 617.20K | 925.20K | 1.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.06M | 6.56M | 6.08M | 5.25M | 4.47M |
| Change in Net Operating Assets | -1.67M | -1.80M | -1.94M | 1.71M | 5.33M |
| Cash from Operations | -9.33M | -8.94M | -8.64M | -8.16M | -7.70M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -300.00 | -600.00 |
| Total Debt Repaid | -- | -- | -- | 400.00 | 800.00 |
| Issuance of Common Stock | 59.36M | 35.92M | 12.48M | 11.17M | 9.85M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 22.20M | 12.85M | 3.50M | 2.31M | 1.12M |
| Cash from Financing | 53.32M | 31.77M | 10.39M | 8.80M | 7.25M |
| Foreign Exchange rate Adjustments | -501.60K | -254.70K | -7.70K | 61.10K | 129.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 43.48M | 22.57M | 1.74M | 703.70K | -324.60K |